US Broker Ratings

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring a 65.75% Potential Upside in the Biotech Sector

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) has captured the attention of investors with its ambitious strides in the biotechnology sector. With a market capitalization of $1.05 billion,..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 58.73% Potential Upside

Individual investors seeking opportunities in the healthcare sector, particularly in regenerative medicine, may find Organogenesis Holdings Inc. (NASDAQ: ORGO) an intriguing prospect. This Massachusetts-based company specializes..

AngioDynamics, Inc. (ANGO) Investor Outlook: A 66% Potential Upside Amidst Healthcare Innovation

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, specializes in the design and manufacturing of advanced medical, surgical, and diagnostic devices. With a..

Treace Medical Concepts, Inc. (TMCI): Investor Outlook with a 15% Upside Potential Amid Revenue Growth

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a key player in the healthcare sector specializing in medical devices, is drawing attention with its innovative solutions for bunion..

Precigen, Inc. (PGEN) Stock Analysis: Unveiling a 99% Upside Potential

In the ever-evolving landscape of biotechnology, Precigen, Inc. (NASDAQ: PGEN) has emerged as a notable player, captivating investor interest with its innovative approach to gene and..

Myriad Genetics (MYGN) Stock Analysis: Navigating Earnings Challenges and Market Opportunities

Myriad Genetics, Inc. (NASDAQ: MYGN) operates at the intersection of molecular diagnostics and precision medicine, offering an extensive array of genetic testing services. Despite its innovative..

Altimmune, Inc. (ALT) Stock Analysis: Exploring a 366% Potential Upside in Biotech Innovation

Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, stands at a fascinating juncture with a compelling potential upside of 366.12%. As a player in the biotechnology..

Oruka Therapeutics, Inc. (ORKA)

⚠️ No article content returned.

..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges in the Healthcare Sector

Sonida Senior Living, Inc. (NASDAQ: SNDA), a prominent player in the healthcare sector, operates senior housing communities across the United States. With a market capitalization of..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a 42% Upside Potential in Biotech Innovation

Prothena Corporation plc (NASDAQ: PRTA) is carving a niche for itself in the biotechnology sector with a focus on innovative therapies for diseases caused by protein..

SIGA Technologies Inc. (SIGA): Investor Outlook on a High-Growth Pharma Player with Robust Revenue Surge

SIGA Technologies Inc. (NASDAQ: SIGA), a noteworthy player in the healthcare sector, is capturing investor attention with its remarkable revenue growth. As a commercial-stage pharmaceutical company,..

Rapport Therapeutics, Inc. (RAPP) Stock Report: Exploring a 130% Potential Upside in the Biotech Arena

Rapport Therapeutics, Inc. (RAPP) is a promising player in the biotechnology industry, focusing on developing groundbreaking small molecule medicines to address central nervous system (CNS) disorders...

Enhabit, Inc. (EHAB) Stock Analysis: Exploring a 15.6% Potential Upside in the Healthcare Sector

Investors looking for opportunities in the healthcare sector might find Enhabit, Inc. (EHAB) an intriguing prospect. As a provider of home health and hospice services in..

Auna SA (AUNA) Stock Analysis: Healthcare Play with Nearly 90% Upside Potential

Auna SA (AUNA), a healthcare service provider headquartered in Luxembourg, is attracting keen interest from investors due to its significant upside potential. With operations spanning hospitals..

Autolus Therapeutics (AUTL) Investor Outlook: A 573% Potential Upside in T Cell Therapy

Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company based in the United Kingdom, is garnering significant attention in the biotechnology sector. With a market capitalization..

Butterfly Network, Inc. (BFLY) Stock Analysis: A Promising 104.30% Upside Potential for Healthcare Innovators

Butterfly Network, Inc. (NASDAQ: BFLY) is carving out a niche in the healthcare sector with its innovative approach to ultrasound imaging solutions. With a market capitalization..

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: Exploring a 158% Potential Upside in Retinal Therapeutics

Investors with a keen eye on the biotechnology sector should pay close attention to EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a promising player in the healthcare industry..

Inventiva S.A. (IVA) Stock Analysis: Unveiling a 143% Potential Upside in the Booming Biotechnology Sector

Investors with a keen eye on the biotechnology sector might find Inventiva S.A. (IVA) an intriguing prospect, especially given the stock’s potential upside of 143.15%. Operating..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating the Biotech Terrain with a 7.20% Revenue Growth

Fortrea Holdings Inc. (FTRE), a contract research organization based in Durham, North Carolina, is making waves in the biotechnology sector. Specializing in biopharmaceutical product and medical..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges in the Medical Device Sector

Surmodics, Inc. (SRDX), a notable player in the healthcare sector specializing in medical devices, presents a complex investment narrative influenced by current market dynamics and performance..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds